Highlights
NASDAQ: ARGX       Argenx Se Ads
Last Price Today's Change   Day's Range   Trading Volume
144.75   -8.76 (5.71%)  144.00 - 149.91  90,200

Overview

 
Avg Volume (4 weeks):159,505
4 Weeks Range:144.00 - 169.50
4 Weeks Price Volatility (%):
2.94%
52 Weeks Range:101.53 - 169.50
52 Weeks Price Volatility (%):
63.59%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

argenx NV, formerly arGEN X BV is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.

  Be the first to like this.
 


 

1843  6298  540  225 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers